General Information of Drug (ID: DM177J3)

Drug Name
RO-5303253
Indication
Disease Entry ICD 11 Status REF
Hepatitis C virus infection 1E51.1 Phase 1 [1]
Cross-matching ID
TTD ID
D02YZK

References

1 ClinicalTrials.gov (NCT01181024) A Study on Safety, Tolerability and Pharmacokinetics of RO5303253 in Healthy Volunteers and Patients With Chronic Hepatitis C Genotype 1. U.S. National Institutes of Health.